Finding a cure for neurodegenerative diseases such as Alzheimer’s is challenging. They’re difficult to diagnose, and drugs struggle to get into the brain as the brain’s blood supply is largely separate to the rest of the body. Not surprisingly, several companies have left this territory in recent years. Last week, pharmaceutical giant Pfizer announced it will stop research into developing drugs to treat Alzheimer’s disease, after costly failed attempts over the past decade.
In recent years some clinical trials involving potential...
Director Of The Clem Jones Centre For Ageing Dementia Research
Professor Jürgen Götz is the Foundation Chair of Dementia Research and Director of the Clem Jones Centre for Ageing Dementia Research (CJCADR) at the Queensland Brain Institute (QBI), The University of Queensland.